AI
Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
RDMD Secures $14 Million in Series A Financing and Announces Partnership with UCB in Rare Neurodegenerative Disease
RDMD Secures $14 Million in Series A Financing and Announces Partnership with UCB in Rare Neurodegenerative Disease
04/16/20, 12:36 PM
Location
san francisco
Money raised
$14 million
Round Type
series a
RDMD, a healthcare technology company dedicated to accelerating drug research for patients with rare diseases, today announced that it has raised $14 million in Series A financing. RDMD has developed an FDA-ready technology platform that generates deep clinical evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to participate in research from home. In conjunction with the financing, RDMD has also announced progress to date in these efforts.
Company Info
Company
Rdmd
Location
san francisco, california, united states
Additional Info
RDMD is a healthcare technology company dedicated to accelerating treatments for patients with rare diseases. RDMD has developed a technology platform that generates FDA-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in drug research online and benefit from their own medical data. RDMD was founded by co-founder and CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, Spark Capital, Maveron Capital, Village Global, Garuda Ventures and a number of angel investors. For more information, visit www.rdmd.com.
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.